SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-051195
Filing Date
2023-11-02
Accepted
2023-11-02 17:00:27
Documents
15
Period of Report
2023-10-30
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20009756x13_8k.htm   iXBRL 8-K 47441
2 EXHIBIT 10.1 ny20009756x13_ex10-1.htm EX-10.1 53962
3 EXHIBIT 10.2 ny20009756x13_ex10-2.htm EX-10.2 54678
4 EXHIBIT 16.1 ny20009756x13_ex16-1.htm EX-16.1 4025
  Complete submission text file 0001140361-23-051195.txt   330134

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA gyre-20231030.xsd EX-101.SCH 3907
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE gyre-20231030_lab.xml EX-101.LAB 22546
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gyre-20231030_pre.xml EX-101.PRE 16072
9 EXTRACTED XBRL INSTANCE DOCUMENT ny20009756x13_8k_htm.xml XML 4205
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 250 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 250 SAN DIEGO CA 92130 650-266-8674
GYRE THERAPEUTICS, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 231373396
SIC: 2834 Pharmaceutical Preparations